A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital

Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to sugg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of biomedical science 2007-01, Vol.64 (2), p.63-65
Hauptverfasser: Amess, J.A., O'neill, W., Giollariabhaigh, Ni, Dytrych, J.K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 2
container_start_page 63
container_title British journal of biomedical science
container_volume 64
creator Amess, J.A.
O'neill, W.
Giollariabhaigh, Ni
Dytrych, J.K.
description Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered.
doi_str_mv 10.1080/09674845.2007.11732757
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_09674845_2007_11732757</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1448299581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-9e0ca66a08ac53f6f20fd211cc6a731033285b5b6b2f92df8628b32c9ad732713</originalsourceid><addsrcrecordid>eNqFkc1u1DAURi0EotPCK1QWC3YZ_JPY8XJUUUCqxAbW1o1jM64SO9iOShd99zqaqZDYsLJlnfv56jsIXVOyp6Qnn4gSsu3bbs8IkXtKJWeyk6_QjrWybUivxGu026Bmoy7QZc73hFDFpHiLLqgUnFOudujpgLP_08wxlCOGdfQFR4fL0WKf4wTFx7A93K45DmCKTX6dcbAmxeUYU727FGe8VNCGkvGDrzE5JlsjUoSCfcCAR59L8qbgXzbYBBM-xrz4AtM79MbBlO3783mFft5-_nHztbn7_uXbzeGuMVy1pVGWGBACSA-m4044RtzIKDVGgOSUcM76bugGMTCn2Oh6wfqBM6Ng3Hqh_Ap9POUuKf5ebS569tnYaYJg45q1JJIRzroKfvgHvI9rCnU3zZhUrFbPKiROUG0h52SdXpKfIT1qSvRmR7_Y0Zsd_WKnDl6f09dhtuPfsbOOChxOgA8uphkeYppGXeBxisklCMZnzf_zyTPclqAz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227920802</pqid></control><display><type>article</type><title>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Amess, J.A. ; O'neill, W. ; Giollariabhaigh, Ni ; Dytrych, J.K.</creator><creatorcontrib>Amess, J.A. ; O'neill, W. ; Giollariabhaigh, Ni ; Dytrych, J.K.</creatorcontrib><description>Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered.</description><identifier>ISSN: 0967-4845</identifier><identifier>EISSN: 2474-0896</identifier><identifier>DOI: 10.1080/09674845.2007.11732757</identifier><identifier>PMID: 17633139</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Corynebacterium diphtheriae ; Diphtheria - diagnosis ; Disk Diffusion Antimicrobial Tests ; Female ; Fever ; Fusobacterium Infections - diagnosis ; Fusobacterium necrophorum ; Fusobacterium necrophorum - isolation &amp; purification ; Hospitals ; Hospitals, District ; Hospitals, General ; Humans ; Infant ; Male ; Medical Audit - methods ; Middle Aged ; Patients ; Pharyngitis ; Pharyngitis - microbiology ; Pharynx - microbiology ; Prevalence ; Recurrence ; Streptococcal infections ; Streptococcal Infections - diagnosis ; Streptococcus pyogenes - isolation &amp; purification ; Studies</subject><ispartof>British journal of biomedical science, 2007-01, Vol.64 (2), p.63-65</ispartof><rights>Copyright 2007 Taylor and Francis Group LLC 2007</rights><rights>Copyright Step Communications Ltd. 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-9e0ca66a08ac53f6f20fd211cc6a731033285b5b6b2f92df8628b32c9ad732713</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17633139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amess, J.A.</creatorcontrib><creatorcontrib>O'neill, W.</creatorcontrib><creatorcontrib>Giollariabhaigh, Ni</creatorcontrib><creatorcontrib>Dytrych, J.K.</creatorcontrib><title>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</title><title>British journal of biomedical science</title><addtitle>Br J Biomed Sci</addtitle><description>Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Corynebacterium diphtheriae</subject><subject>Diphtheria - diagnosis</subject><subject>Disk Diffusion Antimicrobial Tests</subject><subject>Female</subject><subject>Fever</subject><subject>Fusobacterium Infections - diagnosis</subject><subject>Fusobacterium necrophorum</subject><subject>Fusobacterium necrophorum - isolation &amp; purification</subject><subject>Hospitals</subject><subject>Hospitals, District</subject><subject>Hospitals, General</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medical Audit - methods</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Pharyngitis</subject><subject>Pharyngitis - microbiology</subject><subject>Pharynx - microbiology</subject><subject>Prevalence</subject><subject>Recurrence</subject><subject>Streptococcal infections</subject><subject>Streptococcal Infections - diagnosis</subject><subject>Streptococcus pyogenes - isolation &amp; purification</subject><subject>Studies</subject><issn>0967-4845</issn><issn>2474-0896</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc1u1DAURi0EotPCK1QWC3YZ_JPY8XJUUUCqxAbW1o1jM64SO9iOShd99zqaqZDYsLJlnfv56jsIXVOyp6Qnn4gSsu3bbs8IkXtKJWeyk6_QjrWybUivxGu026Bmoy7QZc73hFDFpHiLLqgUnFOudujpgLP_08wxlCOGdfQFR4fL0WKf4wTFx7A93K45DmCKTX6dcbAmxeUYU727FGe8VNCGkvGDrzE5JlsjUoSCfcCAR59L8qbgXzbYBBM-xrz4AtM79MbBlO3783mFft5-_nHztbn7_uXbzeGuMVy1pVGWGBACSA-m4044RtzIKDVGgOSUcM76bugGMTCn2Oh6wfqBM6Ng3Hqh_Ap9POUuKf5ebS569tnYaYJg45q1JJIRzroKfvgHvI9rCnU3zZhUrFbPKiROUG0h52SdXpKfIT1qSvRmR7_Y0Zsd_WKnDl6f09dhtuPfsbOOChxOgA8uphkeYppGXeBxisklCMZnzf_zyTPclqAz</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Amess, J.A.</creator><creator>O'neill, W.</creator><creator>Giollariabhaigh, Ni</creator><creator>Dytrych, J.K.</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</title><author>Amess, J.A. ; O'neill, W. ; Giollariabhaigh, Ni ; Dytrych, J.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-9e0ca66a08ac53f6f20fd211cc6a731033285b5b6b2f92df8628b32c9ad732713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Corynebacterium diphtheriae</topic><topic>Diphtheria - diagnosis</topic><topic>Disk Diffusion Antimicrobial Tests</topic><topic>Female</topic><topic>Fever</topic><topic>Fusobacterium Infections - diagnosis</topic><topic>Fusobacterium necrophorum</topic><topic>Fusobacterium necrophorum - isolation &amp; purification</topic><topic>Hospitals</topic><topic>Hospitals, District</topic><topic>Hospitals, General</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medical Audit - methods</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Pharyngitis</topic><topic>Pharyngitis - microbiology</topic><topic>Pharynx - microbiology</topic><topic>Prevalence</topic><topic>Recurrence</topic><topic>Streptococcal infections</topic><topic>Streptococcal Infections - diagnosis</topic><topic>Streptococcus pyogenes - isolation &amp; purification</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amess, J.A.</creatorcontrib><creatorcontrib>O'neill, W.</creatorcontrib><creatorcontrib>Giollariabhaigh, Ni</creatorcontrib><creatorcontrib>Dytrych, J.K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>UK &amp; Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of biomedical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amess, J.A.</au><au>O'neill, W.</au><au>Giollariabhaigh, Ni</au><au>Dytrych, J.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</atitle><jtitle>British journal of biomedical science</jtitle><addtitle>Br J Biomed Sci</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>64</volume><issue>2</issue><spage>63</spage><epage>65</epage><pages>63-65</pages><issn>0967-4845</issn><eissn>2474-0896</eissn><abstract>Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>17633139</pmid><doi>10.1080/09674845.2007.11732757</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0967-4845
ispartof British journal of biomedical science, 2007-01, Vol.64 (2), p.63-65
issn 0967-4845
2474-0896
language eng
recordid cdi_crossref_primary_10_1080_09674845_2007_11732757
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Corynebacterium diphtheriae
Diphtheria - diagnosis
Disk Diffusion Antimicrobial Tests
Female
Fever
Fusobacterium Infections - diagnosis
Fusobacterium necrophorum
Fusobacterium necrophorum - isolation & purification
Hospitals
Hospitals, District
Hospitals, General
Humans
Infant
Male
Medical Audit - methods
Middle Aged
Patients
Pharyngitis
Pharyngitis - microbiology
Pharynx - microbiology
Prevalence
Recurrence
Streptococcal infections
Streptococcal Infections - diagnosis
Streptococcus pyogenes - isolation & purification
Studies
title A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A43%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20six-month%20audit%20of%20the%20isolation%20of%20Fusobacterium%20necrophorum%20from%20patients%20with%20sore%20throat%20in%20a%20district%20general%20hospital&rft.jtitle=British%20journal%20of%20biomedical%20science&rft.au=Amess,%20J.A.&rft.date=2007-01-01&rft.volume=64&rft.issue=2&rft.spage=63&rft.epage=65&rft.pages=63-65&rft.issn=0967-4845&rft.eissn=2474-0896&rft_id=info:doi/10.1080/09674845.2007.11732757&rft_dat=%3Cproquest_cross%3E1448299581%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227920802&rft_id=info:pmid/17633139&rfr_iscdi=true